StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

HCW Biologics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

HCW Biologics's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.14M. For fiscal 2025 it was -$13.39M. The highest annual figure on record is -$10.39M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.39M–
FY2024Dec 31, 2024-$14.23M–
FY2023Dec 31, 2023-$22.51M–
FY2022Dec 31, 2022-$10.39M–
FY2021Dec 31, 2021-$10.98M–
FY2020Dec 31, 2020-$10.43M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.97M–
Q1 FY2026Mar 31, 2026-$1.58M–
Q4 FY2025Dec 31, 2025-$3.36M–
Q3 FY2025Sep 30, 2025-$3.24M–
Q2 FY2025Jun 30, 2025-$3.28M–
Q1 FY2025Mar 31, 2025-$3.51M–
Q4 FY2024Dec 31, 2024-$2.83M–
Q3 FY2024Sep 30, 2024-$2.93M–
Q2 FY2024Jun 30, 2024-$4.86M–
Q1 FY2024Mar 31, 2024-$3.60M–
Q4 FY2023Dec 31, 2023-$3.89M–
Q3 FY2023Sep 30, 2023-$5.59M–
Q2 FY2023Jun 30, 2023-$9.39M–
Q1 FY2023Mar 31, 2023-$3.64M–
Q4 FY2022Dec 31, 2022-$3.79M–
Q3 FY2022Sep 30, 2022-$2.31M–
Q2 FY2022Jun 30, 2022-$2.69M–
Q1 FY2022Mar 31, 2022-$1.59M–
Q4 FY2021Dec 31, 2021-$3.38M–
Q3 FY2021Sep 30, 2021-$5.12M–
Q2 FY2021Jun 30, 2021-$990.44K–
Q1 FY2021Mar 31, 2021-$1.49M–
Q4 FY2020Dec 31, 2020-$3.54M–
Q3 FY2020Sep 30, 2020-$2.75M–

More HCW Biologics figures

See a number that looks wrong?